|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,018.87 USD | -0.25% |
|
+2.93% | -5.19% |
| May. 20 | Eli Lilly Buys Engage Biologics for Up to $202 Million | DJ |
| May. 20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- LLY Stock
- Consensus Eli Lilly and Company
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
